Skip to main content
Skip to content
Case File
sd-10-EFTA01389338Dept. of JusticeOther

EFTA Document EFTA01389338

GLOUSI 33 Georgetown University Endowment Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund IV, LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchmarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchma

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01389338
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GLOUSI 33 Georgetown University Endowment Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund IV, LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchmarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchma

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GLOUSI 33 Georgetown University Endowment Section 2: Investment Performance Glendower Capital Secondary Opportunities Fund IV, LP In Exhibit 2 each of SOF. SOF D. SOF II and SOF III is benchmarked against its vintage peer group reported in the Cambridge Associates Secondaries Benchmark statistics (September 30, 2017). The SOF Funds present comparatively strong Net IRR. DPI and TVPI across each vintage year. Exhibit 2: SOF Funds performance versus Cambridge Associates Secondary Fund Benchmark " 34 37 Secondary funds: Net IRR to limited partners Secondary funds: Net multiple to limited partners sow 'S. 200. " ss, 64 • :Apt. (4ann Low "J.,* • wads, • ; sac SOf 0% sy. t i; t 2* l td I It as. Iv" = I SC DPI • I it, 00 03 It. ! 04 t• Sao 2. Ce. 3 SO; or. twi ; I pP e II iVAr I3. OF' • 0L I . or te *C9 10 11 12 13 11 ohm OM no* inn r as Imo CPI SC, tea RYPI In Exhibit 3. each of SOF. SOF D. SOF II and SOF III is benchmarked against its vintage group of top quartile buyout funds reported in the Cambridge Associates Global Buyout Benchmark as of September 30. 2017. Again, the SOF Funds present comparatively strong Net IRR, DPI and TVPI across each vintage year. Exhibit 3: Buyout•hke returns with a secondary risk profiles vlw OPP n 9:4 I 3. Os. 0:' Xdf. PA 1,A .coi .R4 Alt Ar. nr) I Wee 0. • s..s itw•s• • WI • )1* 1 • IMF D tt an] 2/%1 Ni • oc= xy, 5 &Of. .1ift sot art 0 Some: Cambridge Associates Secondaries Benchmark statistics as of September 30 2017 SOF Funds are shown benchmarked against their vintage yew peer group SOF and SOF 0 performance is not included m the data se teed to calculate the tenclvnark data Note that the performance fumes in respect el SW and SOF D have not been audried and should be reed and reviewed in conmiteco win Appendix 5 ImponanIPmlonnance latirmatton Past pedamance of SOF Fields 6 not a predecton of Mute performance. Information presented n Exhibt 21s based cn the unzip:Med results ol SOF, SOF D. SOF II and SOF III as of September 30. 2017 Past performance is not a ofeckbon of the future performance of SOF, SOF D. SOF II or SOF III In is included to demaigrate the track record or the Glendower SOF Team There can be no aesurance that SOF fif win achieve canceratle results or that any target resultswill be acrewed DPI = Cierbulons to Paid-in Capital. RVOI = Residual Value to Peel- In Capital. TVPI = Total Value to Paid-in Capital Source' Cambridge Associates Global Buyout Benctimaik as of September 30. 2017. The information reflects a comparison of SOF. SOF D. SOF II a SCf HI performance against one benchmark only Past performance 6 not a prediction ol the Uwe performance of SOF. SOF D, SOF II. SCf III or any other Glendower finds and there can be no asswance that SOF W vall achieve comparatte resifts or that any Impel results will be achieved. but is included to demonstrate the track record of the Glendower SOF Team Interne= presented in this chart is based on the unaudted issues of SOF. SOF D. 9CF II and SOF III as of September 30.2017 and should be read and reviewed in COnpnetCn and Mold be read and ICV,OW•d in conjunction with Appendix 5 inmalant Pet nine Information which sets forth amongst other throe: important infamation regarding the performance emoted above Confidential Prrrate Placement Memorandum 9 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0093694 CONFIDENTIAL SDNY_GM_00239878 EFTA01389338

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.